Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pdk 1'

Search results for: 'research area pi3k akt signaling pdk 1'

Items 11-20 of 22

Page
per page
  1. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  2. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  3. Bumetanide
    A1855 Bumetanide
    Target: Na /K /Cl- Symporters (NKCCs)
    Summary: NKCC cotransporter inhibitor
      insoluble in H2O; ≥36.37 mg/mL
  4. BI-D1870
    B2227 BI-D1870
     1 Citation
    Target: p90 S6K
    Summary: P90 RSK inhibitor,ATP-competitive and cell-permeable
      insoluble in H2O; ≥19.55 mg/mL
  5. XMD17-109
    A3942 XMD17-109
    Target: ERK
    Summary: ERK-5 inhibitor
      ≥31.95 mg/mL
  6. PD 169316
    A8689 PD 169316
    Target: p38
    Summary: P38 MAPK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.3 mg/mL
  7. Refametinib
    B1267 Refametinib
    Target: MEK
    Summary: MEK 1/ MEK 2 inhibitor
      insoluble in H2O; ≥151.8 mg/mL
  8. Anisomycin
    B6674 Anisomycin
    Target: p38|JNK|SAPK
    Summary: JNK agonist, potent and specific
      ≥26.5 mg/mL
  9. PD318088
    A5707 PD318088
    Target: MEK
    Summary: Allosteric MEK1/2 inhibitor, non-ATP competitive
      ≥28.05 mg/mL
  10. VX-745
    A8686 VX-745
    Target: p38
    Summary: P38α inhibitor,highly potent and selective
      ≥21.8 mg/mL

Items 11-20 of 22

Page
per page